{"title":"Coumarin–amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition","link":"http://pubs.rsc.org/en/Content/ArticleLanding/2024/RA/D4RA04226C","date":null,"content":"<div><p><img src=\"/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D4RA04226C\" /></p></div><div><i><b>RSC Adv.</b></i>, 2024, <b>14</b>,24671-24686<br /><b>DOI</b>: 10.1039/D4RA04226C, Paper</div><div><img alt=\"Open Access\" src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png\" /> Open Access</div><div><a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\"> <img src=\"http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png\" alt=\"Creative Commons Licence\" /></a>  This article is licensed under a <a href=\"http://creativecommons.org/licenses/by-nc/3.0/\" target=\"_blank\">Creative Commons Attribution-NonCommercial 3.0 Unported Licence.</a></div><div>Abd-Allah S. El-Etrawy, Ahmad Ramadan, Farag F. Sherbiny, I. F. Zeid, A. A.-H. Abdel-Rahman, Mohamed A. Hawata<br />A new series of amino acid derivatives linked to coumarin has been synthesized as CK2 inhibitors. Compound <strong>7c</strong> outperforms doxorubicin in cell lines, while compound <strong>5b</strong> shows superior CK2 inhibition compared to roscovetine.<br />The content of this RSS Feed (c) The Royal Society of Chemistry</div>","author":"","siteTitle":"RSC - RSC Adv. latest articles","siteHash":"da3e282678330308414c63a405ade89dd3738fcce2936ca8a2fe3a6d7e967d99","entryHash":"c5551d1d69d6fe53d43eb1b7ac73668c15833d6d1455855afaa734e3b7bf5c02","category":"Environment"}